ADAM-17 over-expression in gallbladder carcinoma correlates with poor prognosis of patients.
Wu
Kai
K
The Xiangya Hospital, Central South University, 410011, Changsha, Hunan Province, China.
Liao
Mingmei
M
Liu
Bo
B
Deng
Zhansheng
Z
D051722:ADAM Proteins / Q000096:biosynthesis*; D000072198:ADAM17 Protein; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis*; D015153:Blotting, Western; D002277:Carcinoma / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005706:Gallbladder Neoplasms / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D015854:Up-Regulation
D014408:Biomarkers, Tumor; D051722:ADAM Proteins; D000072198:ADAM17 Protein; C000606462:ADAM17 protein, human